Methionine
Methionine
Price movements (monthly)
veniam aute
Occaecat et deserunt esse duis nulla.
veniam aute
Occaecat et deserunt esse duis nulla.
Methionine China
Month-on-month Change
Year-on-year Change
Methionine Europe
Month-on-month Change
Year-on-year Change
Asia
- The amino acid market has been mostly stable to weak over the past month, driven by new methionine and lysine sulfate capacity and weak downstream demand.
Europe
- A weak trend prevailed for lysine in October, with prices assessed at a midpoint of €1.49/kg on 28 October, their lowest since early 2024. Market sources cited high stock levels in Europe as a key reason preventing the spot prices from rebounding,
North America
- The market was quiet in October, as players await the US government reopening for a countervailing duty decision on lysine from China, with contacts expecting duties of 48% to 58% or higher.
South America
- FOB Sao Paulo Lysine HCl prices firmed in October as sources reported that availability was short as some sellers reduced imports amid the ongoing investigation into the dumping of Chinese-origin lysine.
China’s lysine exports down y-o-y amid anti-dumping duties and investigations
- China’s exports of lysine and threonine declined m-o-m and y-o-y in August amid EU anti-dumping measures against Chinese producers, as well as uncertainty surrounding potential anti-dumping actions from the US and Brazil later this year. Methionine exports from China rose m-o-m and y-o-y driven by increased overseas enquiries ahead of China’s National Day holiday and preparations for the upcoming Christmas season.
Methionine
Price forecast
The price of methionine is currently EUR 2.35 per kg, down from the high seen in Q3 of 2024, when pricing traded at 3.00 EUR/kg. This places the current price in the middle of the fair band, resulting in a neutral stance with no strong upward or downward pressure indicated by the overall fundamental position of the price.
However, it is also important to note that upward pressure is beginning to build from a fundamental perspective, as shown by the fair band's upward movement.
This has yet to translate into higher prices. Seasonal patterns in animal feed demand typically exert upward pressure in the second half of the year, especially in Q3–Q4, creating a window for potential modest price increases.
The European Methionine market is forecast to grow at a CAGR (Compound Annual Growth Rate) of 9.7% from now until 2030, leading to a market valuation of USD 1.2 billion.
Methionine use is dominated by the animal feed sector, specifically the poultry sector, which accounts for more than 90% of production.
With poultry meat consumption continuing to rise, the long-term outlook remains strong with sustained demand for Methionine and related animal feed products.
From a global perspective, the Methionine supply currently matches demand, so any decline in supply could negatively impact prices.
In conclusion, as prices remain within the fair band, the fundamental pressure stays neutral for now. However, it is also important to recognize that the overall fair band is gradually rising from a low observed in Q3 of 2025. If this trend continues, it will support increasing prices in the long term.
Trusted by industry leaders
About Expana
Expana is the world's largest IOSCO-certified agrifood commodity price reporting database
With 36,000+ timely commodity prices and 1,600+ price forecasts across agrifood and industrial markets, you can enhance price visibility throughout your supply chain, reduce costs, lower COGS, and mitigate risk.
Brands by Expana: Mintec Analytics, Urner Barry, Feed Info, Stratégie Grains, Tropical Research Services
Disclaimer
Any forward-looking statements are the views and expectations of the individual market participants. Expana does not have a forward-looking view within this report or associated content. To the extent legally permissible, Expana shall not be liable and disclaims and excludes any and all liability (whether direct or indirect), nor shall Expana be liable in contract, tort (including negligence), misrepresentation (whether innocent or negligent), restitution or otherwise. No information (whether written, electronic or oral) made available herein constitutes or is to be taken as constituting or the giving of investment or financial advice by Expana, or any of its affiliates or their employees to any person, organisation or entity. Any use or reliance on the information and any suggestions, insights or guidance made against such content is entirely at your own risk.
For details on the methodology used to assess the Expana Benchmark Prices, visit this link.